Veterinary Molecular Diagnostics Market Size, Share & Trends Analysis Report, 2032

Veterinary Molecular Diagnostics Market

Veterinary Molecular Diagnostics Market by Technology (Microarrays, Polymerase Chain Reaction (PCR), and DNA Sequencing), by Animal Type (Livestock Animals and Companion Animals), by Disease Indication (Diarrhea Pathogens Detection, Vector-borne Diseases, Respiratory Pathogens Detection, and Others), by Product (Kits & Reagents, Instruments & Software, and Services), and End User (Research Institutes, Clinical Laboratories, and Veterinary Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032

Category: Healthcare Report Format : PDF Pages: 220 Report Code: ZMR-3205 Published Date: Feb-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 2917.84 Million USD 5400.53 Million 7.08% 2023

Veterinary Molecular Diagnostics Market

Veterinary Molecular Diagnostics Industry Prospective:

The global veterinary molecular diagnostics market size was worth around USD 2917.84 million in 2023 and is predicted to grow to around USD 5400.53 million by 2032 with a compound annual growth rate (CAGR) of roughly 7.08% between 2024 and 2032.

Global Veterinary Molecular Diagnostics Market SizeRequest Free Sample

The report covers forecasts and analysis for the veterinary molecular diagnostics market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million). The study includes drivers and restraints for the veterinary molecular diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the veterinary molecular diagnostics market on a global level.

In order to give the users of this report a comprehensive view of the veterinary molecular diagnostics market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segment, technology segment, animal type segment, disease indication segment, and end-user segment are benchmarked based on their market size, growth rate, and general attractiveness.

Molecular diagnostics is the set of techniques used to identify specific sequences in DNA or RNA that could be linked to diseases. Molecular diagnostics techniques help in subclassifying the disease and monitoring response of the treatment. Single Nucleotide Polymorphism (SNP), deletions, insertions, and rearrangements can be identified through molecular diagnostics techniques. Molecular diagnostics helps in developing personalized medicine as it makes it possible to analyze the specifics of patients and their disease. Molecular diagnostics is used in a variety of medical conditions like oncology, genetic disease screening, infectious disease, coagulation, and pharmacogenomics. Molecular diagnostics combines molecular genetics technology and knowledge of genomics.

Over the years, the study of genome has become an important part of medicine and human as well as veterinary health. The discovery of Polymerase Chain Reaction (PCR) played an important part in the widespread adoption of veterinary molecular diagnostics. Extensive research in genetics has given a boost to veterinary molecular diagnostics. Some of the most used veterinary molecular diagnostics techniques include Restriction Fragment Length Polymorphism (RFLP), Allele-Specific Oligonucleotide (ASO) Hybridization, Amplification Refractory Mutation System (ARMS), Oligonucleotide Ligation Assay (OLA), and Pyrosequencing, among others. Polymerase Chain Reaction (PCR) is most commonly used to detect a wide range of viral diseases in animals. Molecular assays are performed for livestock animals for detection and interpretation of diseases.

Veterinary molecular diagnostic techniques are rapidly gaining popularity over traditional testing methods. Polymerase Chain Reaction (PCR), a popular molecular diagnostic technique, is now routinely used in veterinary laboratories. Veterinary molecular diagnostics are extremely crucial during disease outbreaks, as it involves screening of a large number of samples in a short time. According to the European Food Safety Authority (EFSA), around 320,000 cases of foodborne and zoonotic diseases are reported every year. Applying veterinary molecular diagnostic techniques can pave the way for early detection and containment of disease outbreaks in animals.

Global Veterinary Molecular Diagnostics MarketRequest Free Sample

The report provides a company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launches, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis, and the product portfolio of various companies according to the region.

The study provides a decisive view on the veterinary molecular diagnostics market by segmenting the market based on technology veterinary molecular diagnostics market has been segmented into microarrays, polymerase chain reaction (PCR), and DNA sequencing. On the basis of the animal type, the market for veterinary molecular diagnostics is segmented into livestock animals and companion animals. Based on disease indication the veterinary molecular diagnostics market has been segmented into diarrhea pathogens detection, vector-borne diseases, respiratory pathogens detection, and others.

Global Veterinary Molecular Diagnostics Market

The emergence of advanced veterinary molecular diagnostic tools over traditional diagnostic tools and a growing focus on adopted pet’s and livestock’s health and nutrition will drive the growth of veterinary molecular diagnostics market. However, the high costs associated with these techniques could restrict veterinary molecular diagnostics market growth.

Based on technology, the veterinary molecular diagnostics market has been segmented into microarrays, polymerase chain reaction (PCR), and DNA sequencing.

On the basis of animal type, the market for veterinary molecular diagnostics is segmented into livestock animals and companion animals.

Based on disease indication, the veterinary molecular diagnostics market is segmented into diarrhea pathogens detection, vector-borne diseases, respiratory pathogens detection, and others.

Based on products for veterinary molecular diagnostics includes kits & reagents, instruments & software, and services.

Based on The end-user segment for veterinary molecular diagnostics is divided into research institutes, clinical laboratories, and veterinary hospitals.

Veterinary Molecular Diagnostics Market: Report Scope

 

Report Attributes Report Details
Report Name Veterinary Molecular Diagnostics Market
Market Size in 2023 USD 2917.84 Million
Market Forecast in 2032 USD 5400.53 Million
Growth Rate CAGR of 7.08%
Number of Pages 220
Key Companies Covered IDEXX Laboratories, Inc., ABAXIS, Inc., VCA, Inc., Neogen Corporation, Thermo Fisher Scientific, Inc., Zoetis, Inc., GE Healthcare, Heska Corporation, ID.Vet, Virbac, Veterinary Molecular Diagnostics, Inc., AGFA Healthcare, and others.
Segments Covered By Product, By Technology, By Animal Type, By Disease Indication, By End-User, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

 

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S., Canada, U.K., Germany, France, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, Mexico, Argentina, Saudi Arabia, UAE, Qatar, and South Africa. This segmentation includes demand for the veterinary molecular diagnostics market based on technology, animal type, disease indication product, and end-user in all regions and countries.

North America is expected to remain the dominant region over the forecast period for veterinary molecular diagnostics market. Owing to the increasing adoption of companion animals, more people are willing to pay for veterinary care thus the demand for developing new treatment options is growing. All these factors will boost the market in this region. Europe anticipates being the second most dominant marketplace for veterinary molecular diagnostics market due to the presence of advanced livestock industry. The Asia Pacific is expected to grow at the fastest rate driven by high livestock population in India and China.

Some of the key players in veterinary molecular diagnostics are IDEXX Laboratories, Inc., ABAXIS, Inc., VCA, Inc., Neogen Corporation, Thermo Fisher Scientific, Inc., Zoetis, Inc., GE Healthcare, Heska Corporation, ID.Vet, Virbac, Veterinary Molecular Diagnostics, Inc., and AGFA Healthcare.

Veterinary Molecular Diagnostics Market: Competitive Analysis

The global veterinary molecular diagnostics market is dominated by players like:

  • IDEXX Laboratories, Inc.
  • ABAXIS, Inc.
  • VCA, Inc.
  • Neogen Corporation
  • Thermo Fisher Scientific, Inc.
  • Zoetis, Inc.
  • GE Healthcare
  • Heska Corporation
  • ID.Vet
  • Virbac
  • Veterinary Molecular Diagnostics, Inc.
  • AGFA Healthcare

This report segments the global veterinary molecular diagnostics market as follows:

Global Veterinary Molecular Diagnostics Market: Product Segment Analysis

  • Instruments & Software
  • Kits & Reagents 
  • Services

Global Veterinary Molecular Diagnostics Market: Technology Segment Analysis

Global Veterinary Molecular Diagnostics Market: Animal Type Segment Analysis

  • Companion Animals 
  • Livestock Animals

Global Veterinary Molecular Diagnostics Market: Disease Indication Segment Analysis

  • Vector-borne Diseases
  • Respiratory Pathogens Detection
  • Diarrhea Pathogens Detection
  • Others

Global Veterinary Molecular Diagnostics Market: End-User Segment Analysis

  • Veterinary Hospitals
  • Clinical Laboratories
  • Research Institutes

Global Veterinary Molecular Diagnostics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Molecular techniques are widely used in veterinary and livestock research for vaccine development, research on host-pathogen interactions, micro-biome, and resistome (the micro-biome focusing on all antimicrobial resistance genes) analysis, and the development of diagnostic assays and genome analysis to optimize breeding.
 

According to a study, the global veterinary molecular diagnostics market size was worth around USD 2917.84 million in 2023 and is predicted to grow to around USD 5400.53 million by 2032.

The global veterinary molecular diagnostics market is expected to grow at a CAGR of 7.08% during the forecast period.

North America is expected to dominate the veterinary molecular diagnostics market over the forecast period.

The global veterinary molecular diagnostics market is dominated by players like IDEXX Laboratories, Inc., ABAXIS, Inc., VCA, Inc., Neogen Corporation, Thermo Fisher Scientific, Inc., Zoetis, Inc., GE Healthcare, Heska Corporation, ID. Vet, Virbac, Veterinary Molecular Diagnostics, Inc., and AGFA Healthcare, among others.

The veterinary molecular diagnostics market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed